Increased YKL-40 levels in patients with isolated coronary artery ectasia: an observational study

ERDOĞAN T., KOCAMAN S. A., Cetin M., DURAKOĞLUGİL M. E., Kirbas A., CANGA A., ...More

ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY, vol.13, no.5, pp.465-470, 2013 (SCI-Expanded) identifier identifier identifier


Objective: YKL-40, a new biomarker of localized inflammation, is secreted by macrophages within the atherosclerotic plaques. Coronary artery ectasia (CAE) is a clinical entity with unclear etiopathogenesis. Some studies have revealed that CAE may be a form of atherosclerosis that has more localized and intense inflammatory properties than atherosclerosis. The goal of this study was to investigate YKL-40 and C-reactive protein (CRP) levels in patients with isolated CAE compared to patients with normal coronary arteries (NCA) and coronary artery disease (CAD).